CLI Bordeaux Nord Aquitaine

Bordeaux 33300

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Mesothelioma

Studies at this site

• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early